Effectiveness and safety of ustekinumab in pediatric Crohn's disease: Results of the REALITI study.

Key Points

• To evaluate the effectiveness and safety of ustekinumab in treating pediatric Crohn's disease.
• Conducted a clinical trial investigating ustekinumab use in pediatric patients.
• Monitored safety and effectiveness through patient-reported outcomes and clinical assessments.
• Ustekinumab showed significant improvements in disease symptoms.
• Safety profile appeared acceptable with manageable side effects.